Lassen Therapeutics
Home - Lassen
United States · $85.0M raised
- Business Model
- B2B
- Website
- lassentherapeutics.com
- Total Funding
- $85.0M
- Last Round
- $85.0M Series BDec 2023
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.
About
Lassen Therapeutics is combining novel biology with industry-leading technologies to discover and develop a pipeline of biotherapeutics against compelling new targets that are central to diseases with significant unmet needs. The company generates high-quality antibodies with excellent pharmaceutical properties and collaborates with leading academic and industry partners to translate new science into medicines for patients.
Summary
Lassen Therapeutics is a Biotech company based in United States. It has raised $85.0M in total across 1 round, most recently a $85.0M Series B round in Dec 2023. Investors include Catalio Capital Management, Alta Partners and Longwood Fund.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2023
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/lassen-therapeutics"><img src="https://indexed.vc/api/badge/company/lassen-therapeutics" alt="Lassen Therapeutics on Indexed.vc" width="260" height="76" /></a>